Related Experiment Video
Updated: May 16, 2026
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
Published on: January 7, 2019
[Mesenchymal stem cell therapy in heart disease]
João Pedro Lopes1, António Fiarresga, Pedro Silva Cunha
1Hospital de Santa Marta, Centro Hospitalar Lisboa Central, Lisboa, Portugal. joaopedrolopes@sapo.pt
Insights
Mesenchymal stem cells show promise for treating heart disease. Their immunomodulatory properties are being explored in clinical trials for ischemic heart disease, heart failure, and arrhythmias.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Context:
- Cardiovascular diseases remain a leading global cause of death and disability.
- Current treatments for ischemic heart disease offer limited prognostic improvement.
- There is a critical need for novel therapeutic strategies in cardiovascular medicine.
Purpose:
- To review the current understanding and application of mesenchymal stem cells (MSCs) in treating cardiovascular conditions.
- To explore the transition of MSC research from basic science to clinical trials.
- To discuss the future potential of MSCs in cardiology.
Summary:
- Hematopoietic stem cells have been extensively studied, but results have been mixed, prompting research into other cell types.
- Mesenchymal stem cells possess immunomodulatory properties, indicating significant therapeutic potential for cardiac conditions.
- This review covers basic research, translational studies, and clinical trial outcomes for MSCs in ischemic heart disease, heart failure, and arrhythmias.
Impact:
- Highlights the therapeutic potential of mesenchymal stem cells in cardiovascular medicine.
- Provides a comprehensive overview of MSC research for clinicians and researchers.
- Informs future research directions and clinical applications of stem cell therapy for heart disease.
Abstract:
Cardiovascular disease is among the main causes of mortality and morbidity worldwide. Despite significant advances in medical and interventional therapy, the prognosis of conditions such as ischemic heart disease is still dismal. There is thus a need to investigate new therapeutic tools, one of which is stem cell therapy. Hematopoietic stem cells are the most studied type, and the fact that their biology is relatively well understood has led to their being used in preclinical research and clinical trials. However, the results of some of these studies have been controversial, which has opened the way for studies on other cell types, such as mesenchymal stem cells. These cells have immunomodulatory properties which suggest that they have therapeutic potential in cardiology. In the present article, the authors review the state of the art regarding mesenchymal stem cells, from basic and translational research to their use in clinical trials on ischemic heart disease, heart failure and arrhythmias, and discuss possible future uses.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Mesenchymal Stem Cells